New A.I. technology is generating blueprints for microscopic biological mechanisms that can edit your DNA, pointing to a future when scientists can battle illness and diseases with even greater precision and speed than they can today. Described in a research paper published by a startup called Profluent, the technology is based on the same methods that drive ChatGPT. Profluent has not yet put these synthetic gene editors through clinical trials.